10 Matching Annotations
  1. Last 7 days
    1. he proband initially presented with severe heart failure and required heart transplantation at age 14

      Case#: Patient A

      DiseaseAssertion: Dilated Cardiomyopathy (DCM)

      FamilyInfo: Large multigenerational family with DCM. Six family members identified. TPM1 and VCL variants are connected to disease.

      ParentalTesting: Both parents presented with DCM and TPM1 variant c.97G>A.[p.glu33Lys, p.E33K].

      CasePresentingHPOs: HP:0001644 HP:0012664 HP:0001635

      CaseHPOFreeText: severe heart failure and required heart transplant. Left ventricular ejection fraction.

      CaseNotHPOs:unkown

      CaseNotHPOFreeText: unkown

      CasePreviousTesting: unkown

      Genotyping Method: PCR amplification & Sanger sequencing.

      FunctionalAnalysis: functional data support that TPM1 and VCL variants act synergistically to impact cardiomyocyte contractility and sarcomeric organization and suggest that together these variants may perturb sarcomeric–costameric interactions.

      Variant: TPM1 c.97G>A (p.Glu33Lys; E33K)

      ClinVar: not found

      CAID: CA018447

      gnomAD: not reported

      AdditionalInfo:

  2. Oct 2026
    1. The Ca2+handling properties of hiPSC-derived CMs were studied by Ca2+ imaging. HCMT-CMs had significantly more abnormalities than WT-CMs and HCMM-CMs, when all time points in each group were combined (Figure 2(d), n = 6 in statistical analysis, p < 0.05). Spontaneously beating CMs were divided into five different rhythm categories (normal, oscillation, low/middle peaks, double peaks, and plateau abnormality) based on the abnormalities observed in their Ca2+ signals (Figures 2(e) and 2(f)). HCMT-CMs had significantly higher number of double peaks than HCMM-CMs (p < 0.05, n = 6 in statistical analysis) when both cell lines and all time points were combined for each group

      ExperimentName: Ojala 2016 hiPSC-derived CMs

      PatientCell: CL_0002620 (skin fibroblasts)

      GeneFunction: GO:0008016 (regulation of heart contraction)

      GeneAlteration: hiPSC-derived cardiomyocytes (CMs) generated from skin fibroblasts collected from patients carrying a TPM1-Asp175Asn mutation

      FunctionalEvidence: Figure 2 shows enlarged cardiomyocytes (CMs) (a-b), an increase in multinucleated CMs (c), and calcium handling abnormalities (d) for the HCM-TPM1 variant CMs compared to WT CMs.

      FAVariants: NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn), CA018106

    1. the effect of the mutations was a small decrease (5%) in the maximum sliding speed in the presence of saturating calcium (Table)

      ExperimentName: Karibe 2001 In vitro motility

      NonPatientCell: mechanical actin-myosin functional assay

      GeneFunction: GO:0030049 (muscle filament sliding)

      GeneAlteration: PCR-based mutagenesis of Ala to Ser was used at nucleotide position 340 (GenBank M19713) to produce cDNA encoding the V95A variant. This coding sequence was inserted into the pET3d expression vector and the wild-type or mutant tropomoysin protein was expressed in DE3 cells before being purified to homogeneity for use in the in vitro assays.

      FunctionalEvidence: Mutant tropomyosin-containing actin-troponin-tropomyosin filaments combined with rhodamine-phalloidin had slightly decreased (5%) sliding speed on a heavy meromyosin-coated surface compared to wild-type tropomyosin-containing filaments under saturating calcium conditions (Table 1).

      FAVariants: NM_001018005.2(TPM1):c.284T>C (p.Val95Ala), CA017934

    1. plified from DNA derived from affected individuals offamily MI. In addition to the guanine residue at nucleotideposition

      Case#: Family MI, Northern European

      CasePresentingHPOs: HP:0001639

      CaseHPOFreeText:

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting:

      CaseMethod1:

      CaseMethod2:

      CaseGenotypingMethod: PCR amplification followed by Cycle Sequencing

      Variant: The nucleotide variant positions here refer to those described in the initial cloning of the gene in 1988 (PMID: 3336363), but nucleotide G579A here aligns to NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn).

      ClinVar: 12456

      CAID: CA018106

      gnomAD: Grpmax FAF = 7.900e-7, SNV: 15-63060899-G-A, gnomADv4_D175N

      VariantEvidence:

      CaseAddInfo:

      CasePMIDs: PMID:8327508

    2. nucleotide position 595 in exon 5 of the a-tropomyosingene (Figure 2, left). The normal adenine residue was alsoprese

      Case#: Family MZ, Northern European

      CasePresentingHPOs: HP:0001639 ( Hypertrophic cardiomyopathy)

      CaseHPOFreeText:

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting:

      CaseMethod1:

      CaseMethod2:

      CaseGenotypingMethod: PCR amplification followed by Cycle Sequencing

      Variant: The nucleotide variant positions here refer to those described in the initial cloning of the gene in 1988 (PMID: 3336363), but nucleotide A595G here aligns to NM_001018005.2(TPM1):c.539A>G (p.Glu180Gly).

      ClinVar: 12455

      CAID: CA019017

      gnomAD: 15-63060915-A-G not in gnomAD v4.0.0

      VariantEvidence:

      CaseAddInfo:

      CasePMIDs: PMID:8327508

    1. The aspartate-to-asparagine substitution in exon 5 of the α-tropomyosin gene (Asp175Asn, numbered according to Reference 15), which was previously identified in the proband, results from a guanine-to-adenine transition at nucleotide residue 579 (G579A)

      Case#: Proband_DBIII-2, 53 y.o., M

      CasePresentingHPOs: HP:0001712

      CaseHPOFreeText: Max LVWT 18 mm; LA size 40 mm; episode of sustained VT

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting: None

      CaseMethod1: PCR amplification of TPM1 exon 5 followed by cycle sequencing

      CaseMethod2: STR polymorphisms to construct haplotypes

      CaseGenotypingMethod: PCR amplification of TPM1 exon 5 followed by cycle sequencing

      Variant: The nucleotide position 579 refers to that described in the initial cloning of the gene in 1988 (PMID: 3336363), but aligns to NM_001018005.2(TPM1):c.523G>A (p.Asp175Asn).

      ClinVar: ClinVar:12456

      CAID: CA018106

      gnomAD: Grpmax FAF = 7.900e-7, SNV: 15-63060899-G-A, gnomADv4_D175N

      CasePMIDs:

    1. echocardiographic screening of her immediate family revealed that her father and 2 of 3 siblings had cardiac hypertrophy

      FamilyLabel: Van Driest Family

      Family#PresentingHPOs: HP:0001639 (hypertrophic cardiomyopathy)

      FamilyNotHPOs:

      CountryOrigin:

      Ethnicity:

      Race:

      Family#PreviousTesting: Three highly polymorphic markers for each of 9 known HC genes (MYH7, TNNT2, TNNI, TPM1, MYL3, MYL2, MBPC, ACTC, and PRKAG2) were PCR-amplified for haplotype analysis. Only 3 candidate genes, MYL3, TNNT2, and TPM1, were shared by proband, affected siblings, and father.

      Family#Method1: (other) PCR amplification of all protein-coding exons and splice junctions of the 3 candidate genes from genomic DNA was analyzed using DHPLC (denaturing high-performance liquid chromatography).

      Family#Method2: Cycle sequencing was performed on all DHPLC amplicons with abnormal elution profiles (exon 5 of TPM1).

      Family#GenotypingMethod: DHPLC screening followed by cycle sequencing of TPM1 exon 5.

      Affected: 4

      Unaffected:

      Segregations: 3 (Figure 1)

      PublishedLOD: N/A

      eLOD: N/A; < 4 segregations

      AddSegregationInfo:

      ProbandLabel: III-1

      Variant: NM_001018005.2(TPM1):c.554T>G (p.Leu185Arg)

      ClinVar: 31881

      CAID: CA019057

      gnomAD: 15-63060930-T-G has no data in gnomAD v4.0.0

      FamilyAddInfo: TPM1 variant reported as c.T610G (p.L185R), using coding positions relative to GeneBank accession M19713.1?

      FamilyPMIDs:

    2. The proband was an 8-year-old female who died suddenly in 1997. Autopsy revealed signs of cardiac hypertrophy

      Case#: III-1

      CasePresentingHPOs: HP:0001639 (hypertrophic cardiomyopathy); HP:0001645 (sudden cardiac death)

      CaseHPOFreeText:

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting: None for the proband

      CaseMethod1:

      CaseMethod2:

      CaseGenotypingMethod: DNA extracted from paraffin-embedded spleen tissue, taken at autopsy, was subjected to PCR-amplification of TPM1 exon 5 followed by cycle sequencing to confirm presence of the familial TPM1 variant.

      Variant: NM_001018005.2(TPM1):c.554T>G (p.Leu185Arg)

      ClinVar: 31881

      CAID: CA019057

      gnomAD: 15-63060930-T-G has no data in gnomAD v4.0.0

      VariantEvidence: Chang, et al. 2005 (PMID:16043485) demonstrated in ATPase activity assays that myofibrils reconstituted with L185R mutant tropomyosin had an increased sensitivity to calcium compared to wild-type tropomyosin-reconstituted myofibrils.

      CaseAddInfo: No other genes were screened for mutations in this proband.

      CasePMIDs: